The global toxicology testing services market size is accounted at USD 41.24 billion in 2025 and is forecasted to hit around USD 67.34 billion by 2034, representing a CAGR of 5.60% from 2025 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Toxicology Testing Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Toxicology Testing Services Market, by Method
8.1.1. In Vivo Method
8.1.1.1. Market Revenue and Forecast
8.1.2. In Vitro Method
8.1.2.1. Market Revenue and Forecast
8.1.3. In Silico Method
8.1.3.1. Market Revenue and Forecast
9.1. Toxicology Testing Services Market, by Industry
9.1.1. Pharmaceutical and Biotechnology
9.1.1.1. Market Revenue and Forecast
9.1.2. Cosmetics
9.1.2.1. Market Revenue and Forecast
9.1.3. Chemical
9.1.3.1. Market Revenue and Forecast
9.1.4. Medical Devices
9.1.4.1. Market Revenue and Forecast
9.1.5. Others (Food, Agricultural, and Environmental)
9.1.5.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Method
10.1.2. Market Revenue and Forecast, by Industry
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Method
10.1.3.2. Market Revenue and Forecast, by Industry
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Method
10.1.4.2. Market Revenue and Forecast, by Industry
10.2. Europe
10.2.1. Market Revenue and Forecast, by Method
10.2.2. Market Revenue and Forecast, by Industry
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Method
10.2.3.2. Market Revenue and Forecast, by Industry
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Method
10.2.4.2. Market Revenue and Forecast, by Industry
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Method
10.2.5.2. Market Revenue and Forecast, by Industry
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Method
10.2.6.2. Market Revenue and Forecast, by Industry
10.3. APAC
10.3.1. Market Revenue and Forecast, by Method
10.3.2. Market Revenue and Forecast, by Industry
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Method
10.3.3.2. Market Revenue and Forecast, by Industry
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Method
10.3.4.2. Market Revenue and Forecast, by Industry
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Method
10.3.5.2. Market Revenue and Forecast, by Industry
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Method
10.3.6.2. Market Revenue and Forecast, by Industry
10.4. MEA
10.4.1. Market Revenue and Forecast, by Method
10.4.2. Market Revenue and Forecast, by Industry
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Method
10.4.3.2. Market Revenue and Forecast, by Industry
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Method
10.4.4.2. Market Revenue and Forecast, by Industry
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Method
10.4.5.2. Market Revenue and Forecast, by Industry
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Method
10.4.6.2. Market Revenue and Forecast, by Industry
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Method
10.5.2. Market Revenue and Forecast, by Industry
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Method
10.5.3.2. Market Revenue and Forecast, by Industry
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Method
10.5.4.2. Market Revenue and Forecast, by Industry
11.1. Laboratory Corporation of America Holdings
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Charles River Laboratories, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Bureau Veritas
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Eurofins Scientific
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Pharmaceutical Product Development, LLC
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Envigo
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Merck KGaA
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. SGS Group
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Evotec AG
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. WuXi AppTech
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample